Horace E Smith II

  • 597 Citations
19911998

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Pediatrics

Training Experience

1978Residency, Univ. of Illinois at Chicago
1980Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)
1981Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Illinois at Chicago

… → 1975

Fingerprint Dive into the research topics where Horace E Smith II is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Research Output

  • 597 Citations
  • 4 Article

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

Lusher, J. M., Roberts, H. R., Davignon, G., Joist, J. H., Smith, H., Shapiro, A., Laurian, Y., Kasper, C. K. & Mannucci, P. M., Dec 22 1998, In : Haemophilia. 4, 6, p. 790-798 9 p.

Research output: Contribution to journalArticle

  • 187 Scopus citations

    Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors

    Key, N. S., Aledort, L. M., Beardsley, D., Cooper, H. A., Davignon, G., Ewenstein, B. M., Gilchrist, G. S., Gill, J. C., Glader, B., Hoots, W. K., Kisker, C. T., Lusher, J. M., Rosenfield, C. G., Shapiro, A. D., Smith II, H. E. & Taft, E., Dec 1 1998, In : Thrombosis and Haemostasis. 80, 6, p. 912-918 7 p.

    Research output: Contribution to journalArticle

  • 334 Scopus citations

    Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia a patients with inhibitors

    Schmidt, M. L., Gamerman, S., Smith II, H. E., Scott, J. P. & DiMichele, D. M., Jan 1 1994, In : American Journal of Hematology. 47, 1, p. 36-40 5 p.

    Research output: Contribution to journalArticle

  • 58 Scopus citations

    PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR

    Schmidt, M. L., Smith II, H. E., Gamerman, S., DiMichele, D., Glazer, S. & Scott, J. P., Jan 1 1991, In : British Journal of Haematology. 78, 3, p. 460-463 4 p.

    Research output: Contribution to journalArticle

    18 Scopus citations